DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR SODIUM HEPARIN
Clinical Trials for Sodium Heparin
| Trial ID | Title | Status | Sponsor | Phase | Summary |
|---|---|---|---|---|---|
| NCT00000468 | Myocardial Infarction Triage and Intervention Project (MITI) | Completed | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 | To determine the practicality, benefit, and safety of paramedic administration of thrombolytic therapy for acute myocardial infarction. The feasibility of paramedics correctly identifying candidates for thrombolytic therapy following myocardial infarction was assessed in Phase I. In Phase II, pre-hospital thrombolytic therapy was compared with in-hospital thrombolytic therapy. |
| NCT00000468 | Myocardial Infarction Triage and Intervention Project (MITI) | Completed | University of Washington | Phase 3 | To determine the practicality, benefit, and safety of paramedic administration of thrombolytic therapy for acute myocardial infarction. The feasibility of paramedics correctly identifying candidates for thrombolytic therapy following myocardial infarction was assessed in Phase I. In Phase II, pre-hospital thrombolytic therapy was compared with in-hospital thrombolytic therapy. |
| NCT00203580 | Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study) | Completed | Canadian Institutes of Health Research (CIHR) | Phase 4 | The purpose of this study is to assess the long-term treatment of patients with proximal venous thrombosis through the administration of subcutaneous low-molecular-weight heparin (tinzaparin sodium) versus the standard care use of intravenous heparin followed by oral warfarin sodium. |
| NCT00203580 | Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study) | Completed | Dupont Applied Biosciences | Phase 4 | The purpose of this study is to assess the long-term treatment of patients with proximal venous thrombosis through the administration of subcutaneous low-molecular-weight heparin (tinzaparin sodium) versus the standard care use of intravenous heparin followed by oral warfarin sodium. |
| NCT00203580 | Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study) | Completed | LEO Pharma | Phase 4 | The purpose of this study is to assess the long-term treatment of patients with proximal venous thrombosis through the administration of subcutaneous low-molecular-weight heparin (tinzaparin sodium) versus the standard care use of intravenous heparin followed by oral warfarin sodium. |
| NCT00203580 | Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study) | Completed | University of Calgary | Phase 4 | The purpose of this study is to assess the long-term treatment of patients with proximal venous thrombosis through the administration of subcutaneous low-molecular-weight heparin (tinzaparin sodium) versus the standard care use of intravenous heparin followed by oral warfarin sodium. |
| Trial ID | Title | Status | Sponsor | Phase | Summary |
Clinical Trial Conditions for Sodium Heparin
Condition Name
Condition MeSH
Clinical Trial Locations for Sodium Heparin
Trials by Country
Clinical Trial Progress for Sodium Heparin
Clinical Trial Phase
Clinical Trial Sponsors for Sodium Heparin
Sponsor Name
